In MS, clinical and subclinical disease activity can occur
early in the disease course and persist throughout the disease.1-3
|
|
|
Shining a Light on Multiple Sclerosis.
|
References:
|
1.
|
Polman CH, Reingold SC, Banwell, B, et al. Diagnostic
criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol.
2011(2);69:292-302.
|
2.
|
Scott TF, Hackett CT, Quigley MR, Schramke CJ. Relapsing
multiple sclerosis patients treated with disease modifying therapy exhibit
highly variable disease progression: a predictive model. Clin Neurol.
2014(127);86-92.
|
3.
|
Prosperini L, Gallo V, Petsas N, Borriello G, Pozzilli C.
One-year MRI scan predicts clinical response to interferon beta in multiple
sclerosis. Eur J
Neurol. 2009;16(11):1202-1209.
|
4.
|
de Graaf WL, Kilsdonk ID, Lopez-Soriano A, et al. Clinical
application of multi-contrast 7-T MR imaging in multiple sclerosis:
increased lesion detection compared to 3 T confined to grey matter. Eur Radiol.
2013;23(2):528-540.
|
5.
|
Rio J, Nos C, Tintoré M, et al. Assessment of different
treatment failure criteria in a cohort of relapsing–remitting multiple
sclerosis patients treated with interferon β: implications for clinical
trials. Ann Neurol.
2002;52(4):400-406.
|
|
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News
helps to provide educational information for persons affected by MS
Keep current with Multiple Sclerosis news and information
by opting-in to our website: click here – thank you
.===================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews